COSTS OF NEWLY DIAGNOSED NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AMONG MEDICARE BENEFICIARIES, 2004–2008-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

COSTS OF NEWLY DIAGNOSED NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AMONG MEDICARE BENEFICIARIES, 2004–2008

Published:2013-04 Issue:4 Volume:33 Page:854-861
ISSN:0275-004X
Container-title:Retina
language:en
Short-container-title:

Author:

Qualls Laura G.,Hammill Bradley G.,Wang Fang,Lad Eleonora M.,Schulman Kevin A.,Cousins Scott W.,Curtis Lesley H.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology,General Medicine

Reference27 articles.

1. Age-related macular degeneration and blindness due to neovascular maculopathy.;Ferris;Arch Ophthalmol,1984

2. Age-related macular degeneration.;Jager;N Engl J Med,2008

3. Pharmacotherapy for neovascular age-related macular degeneration: an analysis of the 100 2008 medicare fee-for-service part B claims file.;Brechner;Am J Ophthalmol,2011

4. . Cost effectiveness of treatments for wet age-related macular degeneration.;Mitchell;Pharmacoeconomics,2011

5. . The comparative effectiveness and cost-effectiveness of vitreoretinal interventions.;Brown;Curr Opin Ophthalmol,2008

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-vascular endothelial growth factor biosimilars for neovascular age-related macular degeneration;Cochrane Database of Systematic Reviews;2024-06-03

2. Variations in Using Diagnosis Codes for Defining Age-Related Macular Degeneration Cohorts;Informatics;2024-05-01

3. Anti-vascular endothelial growth factor biosimilars for macular degeneration;Cochrane Database of Systematic Reviews;2023-08-04

4. The Prevalence of Diagnosis of Major Eye Diseases and their Associated Payments in the Medicare Fee-for-Service Program;Ophthalmic Epidemiology;2021-09-16

5. Anti-vascular endothelial growth factor in neovascular age-related macular degeneration – a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems;BMC Ophthalmology;2020-07-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3